Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.24
CNMD's Cash to Debt is ranked lower than
86% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. CNMD: 0.24 )
Ranked among companies with meaningful Cash to Debt only.
CNMD' s 10-Year Cash to Debt Range
Min: 0  Med: 0.04 Max: No Debt
Current: 0.24
Equity to Asset 0.53
CNMD's Equity to Asset is ranked lower than
64% of the 283 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. CNMD: 0.53 )
Ranked among companies with meaningful Equity to Asset only.
CNMD' s 10-Year Equity to Asset Range
Min: 0.29  Med: 0.54 Max: 0.93
Current: 0.53
0.29
0.93
Interest Coverage 8.64
CNMD's Interest Coverage is ranked lower than
84% of the 168 Companies
in the Global Medical Devices industry.

( Industry Median: 10000.00 vs. CNMD: 8.64 )
Ranked among companies with meaningful Interest Coverage only.
CNMD' s 10-Year Interest Coverage Range
Min: 1.24  Med: 4.59 Max: 128
Current: 8.64
1.24
128
F-Score: 3
Z-Score: 3.36
M-Score: -2.67
WACC vs ROIC
10.14%
4.34%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 5.89
CNMD's Operating margin (%) is ranked higher than
59% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 3.07 vs. CNMD: 5.89 )
Ranked among companies with meaningful Operating margin (%) only.
CNMD' s 10-Year Operating margin (%) Range
Min: -0.71  Med: 11.49 Max: 20.38
Current: 5.89
-0.71
20.38
Net-margin (%) 3.72
CNMD's Net-margin (%) is ranked higher than
55% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 1.65 vs. CNMD: 3.72 )
Ranked among companies with meaningful Net-margin (%) only.
CNMD' s 10-Year Net-margin (%) Range
Min: -5.13  Med: 5.29 Max: 12.98
Current: 3.72
-5.13
12.98
ROE (%) 4.62
CNMD's ROE (%) is ranked higher than
53% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. CNMD: 4.62 )
Ranked among companies with meaningful ROE (%) only.
CNMD' s 10-Year ROE (%) Range
Min: -4.42  Med: 7.59 Max: 13.96
Current: 4.62
-4.42
13.96
ROA (%) 2.47
CNMD's ROA (%) is ranked higher than
57% of the 322 Companies
in the Global Medical Devices industry.

( Industry Median: 0.05 vs. CNMD: 2.47 )
Ranked among companies with meaningful ROA (%) only.
CNMD' s 10-Year ROA (%) Range
Min: -1.94  Med: 3.53 Max: 11.26
Current: 2.47
-1.94
11.26
ROC (Joel Greenblatt) (%) 12.67
CNMD's ROC (Joel Greenblatt) (%) is ranked higher than
61% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 3.52 vs. CNMD: 12.67 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CNMD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1.79  Med: 23.41 Max: 71.09
Current: 12.67
-1.79
71.09
Revenue Growth (3Y)(%) 1.70
CNMD's Revenue Growth (3Y)(%) is ranked lower than
55% of the 201 Companies
in the Global Medical Devices industry.

( Industry Median: 3.00 vs. CNMD: 1.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CNMD' s 10-Year Revenue Growth (3Y)(%) Range
Min: -0.1  Med: 3.90 Max: 40.8
Current: 1.7
-0.1
40.8
EBITDA Growth (3Y)(%) 33.00
CNMD's EBITDA Growth (3Y)(%) is ranked higher than
89% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 4.10 vs. CNMD: 33.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CNMD' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -35.8  Med: 4.00 Max: 43.5
Current: 33
-35.8
43.5
EPS Growth (3Y)(%) 238.20
CNMD's EPS Growth (3Y)(%) is ranked higher than
97% of the 174 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. CNMD: 238.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CNMD' s 10-Year EPS Growth (3Y)(%) Range
Min: -72  Med: 7.55 Max: 238.2
Current: 238.2
-72
238.2
» CNMD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

CNMD Guru Trades in Q3 2014

Ken Fisher 413,810 sh (+514.87%)
Paul Tudor Jones 24,642 sh (+10.16%)
John Keeley 34,641 sh (unchged)
Chuck Royce 82,200 sh (unchged)
Steven Cohen Sold Out
Joel Greenblatt Sold Out
Mario Gabelli 92,100 sh (-0.22%)
Jim Simons 180,481 sh (-14.37%)
» More
Q4 2014

CNMD Guru Trades in Q4 2014

Chuck Royce 82,200 sh (unchged)
Jim Simons Sold Out
Mario Gabelli 91,700 sh (-0.43%)
Ken Fisher 405,705 sh (-1.96%)
John Keeley 33,341 sh (-3.75%)
Paul Tudor Jones 8,180 sh (-66.80%)
» More
Q1 2015

CNMD Guru Trades in Q1 2015

Mario Gabelli 91,700 sh (unchged)
John Keeley Sold Out
Paul Tudor Jones Sold Out
Chuck Royce 81,500 sh (-0.85%)
Ken Fisher 393,394 sh (-3.03%)
» More
Q2 2015

CNMD Guru Trades in Q2 2015

Chuck Royce 81,500 sh (unchged)
Ken Fisher 391,394 sh (-0.51%)
Mario Gabelli 90,100 sh (-1.74%)
» More
» Details

Insider Trades

Latest Guru Trades with CNMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 52.09
CNMD's P/E(ttm) is ranked lower than
79% of the 156 Companies
in the Global Medical Devices industry.

( Industry Median: 28.20 vs. CNMD: 52.09 )
Ranked among companies with meaningful P/E(ttm) only.
CNMD' s 10-Year P/E(ttm) Range
Min: 9.88  Med: 25.98 Max: 755.25
Current: 52.09
9.88
755.25
Forward P/E 23.53
CNMD's Forward P/E is ranked lower than
53% of the 96 Companies
in the Global Medical Devices industry.

( Industry Median: 23.31 vs. CNMD: 23.53 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 54.90
CNMD's PE(NRI) is ranked lower than
79% of the 155 Companies
in the Global Medical Devices industry.

( Industry Median: 28.40 vs. CNMD: 54.90 )
Ranked among companies with meaningful PE(NRI) only.
CNMD' s 10-Year PE(NRI) Range
Min: 9.92  Med: 26.03 Max: 755.25
Current: 54.9
9.92
755.25
P/B 2.45
CNMD's P/B is ranked higher than
55% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 3.01 vs. CNMD: 2.45 )
Ranked among companies with meaningful P/B only.
CNMD' s 10-Year P/B Range
Min: 0.61  Med: 1.43 Max: 2.88
Current: 2.45
0.61
2.88
P/S 1.94
CNMD's P/S is ranked higher than
60% of the 285 Companies
in the Global Medical Devices industry.

( Industry Median: 3.00 vs. CNMD: 1.94 )
Ranked among companies with meaningful P/S only.
CNMD' s 10-Year P/S Range
Min: 0.48  Med: 1.11 Max: 2.29
Current: 1.94
0.48
2.29
PFCF 27.86
CNMD's PFCF is ranked higher than
61% of the 119 Companies
in the Global Medical Devices industry.

( Industry Median: 33.52 vs. CNMD: 27.86 )
Ranked among companies with meaningful PFCF only.
CNMD' s 10-Year PFCF Range
Min: 7.44  Med: 18.01 Max: 2046
Current: 27.86
7.44
2046
POCF 21.69
CNMD's POCF is ranked lower than
51% of the 157 Companies
in the Global Medical Devices industry.

( Industry Median: 22.08 vs. CNMD: 21.69 )
Ranked among companies with meaningful POCF only.
CNMD' s 10-Year POCF Range
Min: 6.18  Med: 12.81 Max: 138.5
Current: 21.69
6.18
138.5
EV-to-EBIT 37.51
CNMD's EV-to-EBIT is ranked lower than
74% of the 159 Companies
in the Global Medical Devices industry.

( Industry Median: 21.34 vs. CNMD: 37.51 )
Ranked among companies with meaningful EV-to-EBIT only.
CNMD' s 10-Year EV-to-EBIT Range
Min: -226.3  Med: 18.50 Max: 153.1
Current: 37.51
-226.3
153.1
PEG 4.54
CNMD's PEG is ranked lower than
64% of the 59 Companies
in the Global Medical Devices industry.

( Industry Median: 3.01 vs. CNMD: 4.54 )
Ranked among companies with meaningful PEG only.
CNMD' s 10-Year PEG Range
Min: 1.23  Med: 5.73 Max: 240.33
Current: 4.54
1.23
240.33
Shiller P/E 52.57
CNMD's Shiller P/E is ranked lower than
73% of the 96 Companies
in the Global Medical Devices industry.

( Industry Median: 32.28 vs. CNMD: 52.57 )
Ranked among companies with meaningful Shiller P/E only.
CNMD' s 10-Year Shiller P/E Range
Min: 12.05  Med: 27.66 Max: 61.88
Current: 52.57
12.05
61.88
Current Ratio 3.41
CNMD's Current Ratio is ranked higher than
63% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 2.44 vs. CNMD: 3.41 )
Ranked among companies with meaningful Current Ratio only.
CNMD' s 10-Year Current Ratio Range
Min: 1.37  Med: 3.49 Max: 12.38
Current: 3.41
1.37
12.38
Quick Ratio 2.05
CNMD's Quick Ratio is ranked higher than
54% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. CNMD: 2.05 )
Ranked among companies with meaningful Quick Ratio only.
CNMD' s 10-Year Quick Ratio Range
Min: 0.48  Med: 1.56 Max: 8.38
Current: 2.05
0.48
8.38
Days Inventory 162.02
CNMD's Days Inventory is ranked lower than
62% of the 283 Companies
in the Global Medical Devices industry.

( Industry Median: 129.48 vs. CNMD: 162.02 )
Ranked among companies with meaningful Days Inventory only.
CNMD' s 10-Year Days Inventory Range
Min: 136.41  Med: 168.15 Max: 231.38
Current: 162.02
136.41
231.38
Days Sales Outstanding 64.93
CNMD's Days Sales Outstanding is ranked higher than
57% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 69.92 vs. CNMD: 64.93 )
Ranked among companies with meaningful Days Sales Outstanding only.
CNMD' s 10-Year Days Sales Outstanding Range
Min: 42.39  Med: 66.24 Max: 125.1
Current: 64.93
42.39
125.1

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.57
CNMD's Dividend Yield is ranked lower than
54% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 1.65 vs. CNMD: 1.57 )
Ranked among companies with meaningful Dividend Yield only.
CNMD' s 10-Year Dividend Yield Range
Min: 0.5  Med: 1.65 Max: 2.22
Current: 1.57
0.5
2.22
Dividend Payout 0.82
CNMD's Dividend Payout is ranked lower than
86% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 0.35 vs. CNMD: 0.82 )
Ranked among companies with meaningful Dividend Payout only.
CNMD' s 10-Year Dividend Payout Range
Min: 0.4  Med: 0.52 Max: 2.86
Current: 0.82
0.4
2.86
Yield on cost (5-Year) 1.56
CNMD's Yield on cost (5-Year) is ranked lower than
57% of the 184 Companies
in the Global Medical Devices industry.

( Industry Median: 1.63 vs. CNMD: 1.56 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
CNMD' s 10-Year Yield on cost (5-Year) Range
Min: 0.5  Med: 1.65 Max: 2.22
Current: 1.56
0.5
2.22
Share Buyback Rate 1.00
CNMD's Share Buyback Rate is ranked higher than
89% of the 204 Companies
in the Global Medical Devices industry.

( Industry Median: -4.20 vs. CNMD: 1.00 )
Ranked among companies with meaningful Share Buyback Rate only.
CNMD' s 10-Year Share Buyback Rate Range
Min: 1.6  Med: -0.90 Max: -9.7
Current: 1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 231.82
CNMD's Price/Tangible Book is ranked lower than
100% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 4.01 vs. CNMD: 231.82 )
Ranked among companies with meaningful Price/Tangible Book only.
CNMD' s 10-Year Price/Tangible Book Range
Min: 2.46  Med: 6.88 Max: 315.56
Current: 231.82
2.46
315.56
Price/Projected FCF 1.48
CNMD's Price/Projected FCF is ranked higher than
67% of the 112 Companies
in the Global Medical Devices industry.

( Industry Median: 2.02 vs. CNMD: 1.48 )
Ranked among companies with meaningful Price/Projected FCF only.
CNMD' s 10-Year Price/Projected FCF Range
Min: 0.5  Med: 1.00 Max: 1.74
Current: 1.48
0.5
1.74
Price/Median PS Value 1.75
CNMD's Price/Median PS Value is ranked lower than
85% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. CNMD: 1.75 )
Ranked among companies with meaningful Price/Median PS Value only.
CNMD' s 10-Year Price/Median PS Value Range
Min: 0.49  Med: 1.08 Max: 2.72
Current: 1.75
0.49
2.72
Price/Peter Lynch Fair Value 6.75
CNMD's Price/Peter Lynch Fair Value is ranked lower than
95% of the 38 Companies
in the Global Medical Devices industry.

( Industry Median: 2.21 vs. CNMD: 6.75 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
CNMD' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.38  Med: 1.76 Max: 104.57
Current: 6.75
0.38
104.57
Price/Graham Number 23.39
CNMD's Price/Graham Number is ranked lower than
100% of the 138 Companies
in the Global Medical Devices industry.

( Industry Median: 2.50 vs. CNMD: 23.39 )
Ranked among companies with meaningful Price/Graham Number only.
CNMD' s 10-Year Price/Graham Number Range
Min: 1.26  Med: 3.85 Max: 32.17
Current: 23.39
1.26
32.17
Earnings Yield (Greenblatt) (%) 2.59
CNMD's Earnings Yield (Greenblatt) (%) is ranked higher than
62% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.50 vs. CNMD: 2.59 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CNMD' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.7  Med: 5.40 Max: 13.1
Current: 2.59
0.7
13.1
Forward Rate of Return (Yacktman) (%) 11.83
CNMD's Forward Rate of Return (Yacktman) (%) is ranked higher than
73% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 4.79 vs. CNMD: 11.83 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CNMD' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -13.9  Med: 1.80 Max: 21.2
Current: 11.83
-13.9
21.2

Analyst Estimate

Dec15 Dec16 Dec17 Dec18
Revenue(Mil) 729 753 780 809
EPS($) 1.85 2.17 2.51 2.87
EPS without NRI($) 1.85 2.17 2.51 2.87

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:EC8.Germany,
Conmed Corp was incorporated under the laws of the State of New York in 1970. It is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring. The Company's products serve the clinical areas, surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. Effective January 1, 2013, the Company is accounting and reporting business as a single segment entity engaged in the development, manufacturing and sale on a basis of surgical devices and related equipment. The business is derived from sales in orthopedic surgery product lines, including sports medicine, powered surgical instruments and sports biologics and tissue. These lines are marketed under a number of reputable brands, including Hall, CONMED Linvatec, Concept and Shutt. The surgical visualization product line offers endoscopic imaging and capture devices for the complete spectrum of surgical needs including 2DHD and 3DHD vision technologies. The general surgery product line offers in the areas of advanced energy, endomechanical instrumentation, gastrointestinal, pulmonary and patient monitoring. The products are distributed domestically directly to more than 6,000 hospitals and other healthcare institutions as well as through medical specialty distributors and surgeons. The operation of Company are subject, to a number of environmental laws and regulations governing, among other things, air emissions, wastewater discharges, the use, handling and disposal of hazardous substances and wastes, soil and groundwater remediation and employee health and safety.
» More Articles for CNMD

Headlines

Articles On GuruFocus.com
CONMED Corporation Announces Preliminary 2014 Results Within Guidance Range and Issues 2015 Financia Jan 14 2015 
CONMED Corporation to Announce Fourth Quarter 2014 Financial Results on January 27, 2015 Jan 08 2015 
CONMED Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference Dec 11 2014 
CONMED Corporation to Announce Third Quarter 2014 Financial Results on October 23, 2014 Oct 15 2014 
Paulson, Mindich and Soros Bought Covidien; Should You? Sep 11 2014 
Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 
Weekly CEO Sells Highlight: Profire energy Inc, Graphic Packaging Holding Co, Seagate Technology PLC Aug 04 2014 
My 5 Favorite High Beta Health Care Dividend Stocks Aug 02 2013 
CONMED Corp. (CNMD) Vice President/Finance/CFO Robert D Jr Shallish sells 6,151 Shares Feb 07 2011 
CONMED Corp. Reports Operating Results (10-Q) Nov 02 2010 

More From Other Websites
2 Medical Technology Stocks To Weather Market Pullback Aug 25 2015
CONMED CORP Files SEC form 8-K, Other Events Aug 25 2015
CONMED Corporation Announces Quarterly Cash Dividend Aug 24 2015
CONMED Corp. Earnings Q2*, 2015 Aug 18 2015
Sonova Holding AG : Relatively good pick today? Aug 13 2015
CONMED Corporation to Present at Two Investor Conferences in September Aug 12 2015
CONMED Corporation to Present at Two Investor Conferences in September Aug 12 2015
CONMED CORP Financials Jul 30 2015
CONMED CORP Files SEC form 10-Q, Quarterly Report Jul 27 2015
CONMED (CNMD) Posts Q2 Earnings, Revenue Miss; Down Y/Y - Analyst Blog Jul 22 2015
CONMED CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Jul 22 2015
CONMED downgraded by Northland Capital Jul 22 2015
Edited Transcript of CNMD earnings conference call or presentation 21-Jul-15 8:30pm GMT Jul 21 2015
Conmed misses Street 2Q forecasts Jul 21 2015
Conmed misses Street 2Q forecasts Jul 21 2015
Conmed Corp Earnings Call scheduled for 4:30 pm ET today Jul 21 2015
CONMED Corporation Announces Second Quarter 2015 Financial Results Jul 21 2015
CONMED Corporation Announces Second Quarter 2015 Financial Results Jul 21 2015
Q2 2015 Conmed Corp Earnings Release - After Market Close Jul 21 2015
CONMED CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... Jul 01 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK